BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 3277659)

  • 21. Localization of bullous pemphigoid antibody--an indirect immunofluorescence study of 228 cases using a split-skin technique.
    Logan RA; Bhogal B; Das AK; McKee PM; Black MM
    Br J Dermatol; 1987 Oct; 117(4):471-8. PubMed ID: 3314971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA type in bullous pemphigoid, cicatricial pemphigoid and linear IgA disease.
    Venning VA; Taylor CJ; Ting A; Wojnarowska F
    Clin Exp Dermatol; 1989 Jul; 14(4):283-5. PubMed ID: 2686874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection and partial characterization of ocular cicatricial pemphigoid antigens on COLO and SCaBER tumor cell lines.
    Mohimen A; Neumann R; Foster CS; Ahmed AR
    Curr Eye Res; 1993 Aug; 12(8):741-52. PubMed ID: 8222735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies to human alpha6 integrin in patients with oral pemphigoid.
    Bhol KC; Goss L; Kumari S; Colon JE; Ahmed AR
    J Dent Res; 2001 Aug; 80(8):1711-5. PubMed ID: 11669480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunopathological study of bullous pemphigoid, cicatricial pemphigoid and herpes gestationis].
    Barthélémy H; Ohrt C; Thivolet J
    Ann Dermatol Venereol; 1985; 112(5):403-10. PubMed ID: 3898966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
    Brooks WS; Lee YY; Abell E; Deng JS
    J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired bullous diseases of childhood: re-evaluation of diagnosis by indirect immunofluorescence examination on 1 M NaCl split skin and immunoblotting.
    Kirtschig G; Wojnarowska F; Marsden RA; Edwards S; Bhogal B; Black MM
    Br J Dermatol; 1994 May; 130(5):610-6. PubMed ID: 8204469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bullous pemphigoid and antinuclear antibodies. Unmasking of basement membrane fluorescence in sodium chloride-treated substrates.
    Danno K; Okamoto H; Miyauchi H; Imamura S
    Arch Dermatol; 1982 Jan; 118(1):37-9. PubMed ID: 7036909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular overlap of the IgA target antigens in the subepidermal blistering diseases.
    Collier P; Wojnarowska F; Allen J; Kirtschig G
    Dermatology; 1994; 189 Suppl 1():105-7. PubMed ID: 8049544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of cicatricial pemphigoid antigens.
    Niimi Y; Zhu XJ; Bystryn JC
    Arch Dermatol; 1992 Jan; 128(1):54-7. PubMed ID: 1739288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unilateral ocular cicatricial pemphigoid with circulating IgA and IgG autoantibodies reactive with the 180 kD bullous pemphigoid antigen.
    Matsuzaki T; Mashima Y; Idei T; Hashimoto T; Mashima Y
    Br J Ophthalmol; 1996 Aug; 80(8):769. PubMed ID: 8949726
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of a 168-kDa mucosal antigen in a subset of patients with cicatricial pemphigoid.
    Ghohestani RF; Nicolas JF; Rousselle P; Claudy AL
    J Invest Dermatol; 1996 Jul; 107(1):136-9. PubMed ID: 8752852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The predominance of IgG4 in prodromal bullous pemphigoid.
    Lamb PM; Patton T; Deng JS
    Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bullous pemphigoid and cicatricial pemphigoid: immunoblotting detection of involved autoantigens.
    Sarret Y; Reano A; Nicolas JF; Su H; Thivolet J
    Autoimmunity; 1989; 2(2):145-53. PubMed ID: 2491598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Parapemphigus and variants; clinical and immunological aspects].
    Laeijendecker R; Oranje AP; van Joost T
    Ned Tijdschr Geneeskd; 1989 Sep; 133(35):1741-4. PubMed ID: 2677789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of antigens targeted by circulating IgG and IgA antibodies in patients with mucous membrane pemphigoid predominantly affecting the oral cavity.
    Carrozzo M; Cozzani E; Broccoletti R; Carbone M; Pentenero M; Arduino P; Parodi A; Gandolfo S
    J Periodontol; 2004 Oct; 75(10):1302-8. PubMed ID: 15562906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro organ culture model for mucous membrane pemphigoid.
    Colón JE; Bhol KC; Razzaque MS; Ahmed AR
    Clin Immunol; 2001 Feb; 98(2):229-34. PubMed ID: 11161979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localized pemphigoid: a case report showing in situ deposition as well as presence in serum of IgG and IgA anti-basement membrane zone antibodies.
    Sugihara K; Dekio S; Tohgi K; Jidoi J
    J Dermatol; 1987 Feb; 14(1):73-6. PubMed ID: 3301954
    [No Abstract]   [Full Text] [Related]  

  • 39. Bullous pemphigoid: the frequency of mucosal involvement and concurrent malignancy related to indirect immunofluorescence findings.
    Hodge L; Marsden RA; Black MM; Bhogal B; Corbett MF
    Br J Dermatol; 1981 Jul; 105(1):65-9. PubMed ID: 7020742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunopathology of cicatricial pemphigoid: studies of complement deposition.
    Rogers RS; Perry HO; Bean SF; Jordon RE
    J Invest Dermatol; 1977 Jan; 68(1):39-43. PubMed ID: 318674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.